Home› Procurement News - India : Maximum Retail Price of three Anti-cancer Drugs (Trastuzumab, Osimertinib and Durvalumab) to come down on account of exemption from Custom duty and Reduction in GST Rates, India (510007031)

Procurement News

Procurement News
News TI Ref No
510007031
News Date
30 Oct 2024
News Description
India : Maximum Retail Price of three Anti-cancer Drugs (Trastuzumab, Osimertinib and Durvalumab) to come down on account of exemption from Custom duty and Reduction in GST Rates
Tender Deadline
⏰ 30 Oct 2024 Closing soon
News Project Location
- India
News Sector
Retail Tenders
News Document Type
Procurement News
Tender Organization Name
🔒 Members only Click for more details
Tender Organization Name
🔒 Members only Click for more details
Tender Organization Name
🔒 Members only Click for more details
Unlock Full Details — Register Free
Start with receiving Free Data Samples related to your Products and Services
✓
Live Tender Updates from worldwide
✓
Access to original Tender Documents
✓
Information on Upcoming Projects & Contract Awards
✓
Bid Assistance Services
✓
Competitor Analysis & Industry Trends
✓
Daily Custom Email Alerts by Sector & Country

Similar News

View All Retail Tenders Tenders ->

Register to View Tenders

Start Your Business Journey. Register now for 3 days Free Sample Tenders & AI Website Demo.

Already have an account? Login here

By registering you agree to our Terms & Conditions and Privacy Policy.